arrow
Back
K

Karin Holmskov Hansen

Odense University Hospital

16H-index
79Paper Count
1.6KCitation Count
Published Papers 14
Publication Date
Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study)
err2026-02-18
err0
errOAAI
errElin Marie Stensland; Simone Stensgaard; Inger Johanne Z. Eide; Yngvar Nilssen; Henrik Horndalsveen; Saulius Cicenas; Bjørn Henning Grønberg; Simon Ekman; Karin Holmskov Hansen; Boe Sandahl Sorensen; Odd Terje Brustugun
errShare
errSave
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial
err2025-12-01
err0
PREAI
errAhn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N.; Fram, Robert J.; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario Garcia
errShare
errSave
Clinical and molecular characteristics of 42 Danish patients with metastatic ALK fusion-positive lung cancer treated with first-line alectinib: A nationwide study
err2025-09-01
err0
errOAAI
errUlhOi, Maiken Parm; Andersen, Emma Roger; Maansson, Christoffer Trier; Larsen, Lars Munch; Stelmach, Miroslaw; Andersen, Jon Lykkegaard; Hansen, Karin Holmskov; Mcculloch, Tine; Sorensen, Bo; Meldgaard, Peter
errShare
errSave
Mutated TP53 prevalence in EGFR-mutated advanced non-small cell lung cancer patients with brain metastases
err2024-03-22
err0
PREAI
errStensgaard, Simone; Eide, Inger Johanne Z.; Stensland, Elin Marie; Helland, Aslaug; Ekman, Simon; Hansen, Karin H.; Cicenas, Saulius; Gronberg, Bjorn Henning; Meldgaard, Peter; Sorensen, Boe S.; Brustugun, Odd Terje
errShare
errSave
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial
err2023-02-22
err16
errOAAI
errKringelbach, Tina; Hojgaard, Martin; Rohrberg, Kristoffer; Spanggaard, Iben; Laursen, Britt Elmedal; Ladekarl, Morten; Haslund, Charlotte Aaquist; Harslof, Laurine; Belcaid, Laila; Gehl, Julie; Sondergaard, Lise; Eefsen, Rikke Lovendahl; Hansen, Karin Holmskov; Kodahl, Annette Raskov; Jensen, Lars Henrik; Holt, Marianne Ingerslev; Oellegaard, Trine Heide; Yde, Christina Westmose; Ahlborn, Lise Barlebo; Lassen, Ulrik
errShare
errSave
Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy
err2023-01-01
err9
PREAI
errBjornhart, Birgitte; Kristiansen, Charlotte; Asmussen, Jon; Hansen, Karin Holmskov; Wedervang, Kim; Jorgensen, Trine Lembrecht; Herrstedt, Jorn; Schytte, Tine
errShare
errSave
Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALKþ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials
err2022-09-01
err15
errOAAI
errGettinger, Scott N.; Huber, Rudolf M.; Kim, Dong-Wan; Bazhenova, Lyudmila; Hansen, Karin Holmskov; Tiseo, Marcello; Langer, Corey J.; Rodriguez, Luis G. Paz-Ares; West, Howard L.; Reckamp, Karen L.; Weiss, Glen J.; Smit, Egbert F.; Hochmair, Maximilian J.; Kim, Sang-We; Ahn, Myung-Ju; Kim, Edward S.; Groen, Harry J. M.; Pye, Joanna; Liu, Yuyin; Zhang, Pingkuan; Vranceanu, Florin; Camidge, Ross
errShare
errSave
Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials
err2022-06-01
err17
errOAAI
errEide, Inger Johanne Zwicky; Stensgaard, Simone; Helland, Aslaug; Ekman, Simon; Mellemgaard, Anders; Hansen, Karin Holmskov; Cicenas, Saulius; Koivunen, Jussi; Gronberg, Bjorn Henning; Sorensen, Boe Sandahl; Brustugun, Odd Terje
errShare
errSave
Intracranial response (ICR) following immunotherapy in non-small cell lung cancer (NSCLC) patients with untreated brain metastasis (BM)
err2021-09-01
err0
errOAAI
errBjoernhart, B.; Hansen, K. H.; Asmussen, J. T.; Jorgensen, T. L.; Herrstedt, J.; Schytte, T.
errShare
errSave
How to select cancer patients for immunotherapy
err2021-01-01
err1
errOAAI
errPfeiffer, Per; Qvortrup, Camilla; Hansen, Karin Holmskov
errShare
errSave
Impact of comorbidity and venous thromboembolism on outcome in real-life non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibition (ICI)
err2020-12-01
err0
errOAAI
errBjoernhart, B.; Kristiansen, C.; Hansen, K. H.; Wedervang, K.; Nyhus, C. H.; Jorgensen, T. L.; Herrstedt, J.; Schytte, T.
errShare
errSave
Real word experience with first-line immunotherapy in advanced non-small cell lung cancer patients in a Danish nationwide cohort
err2020-09-01
err1
errOAAI
errMouritzen, M.; Bjoernhart, B.; Poehl, M.; Ladekarl, M.; Vesteghem, C.; Boegsted, M.; Nielsen, A. W. Moelby; Meldgaard, P.; Hansen, K. H.; Larsen, J. W. W.; Kristiansen, C.; Wedervang, K.; Bareid-Oestby, A-C.; Frank, M. S.; Persson, G.; Kristensen, E. B.; Homann, H.; Carus, A.
errShare
errSave
The influence of polypharmacy on outcome in real life non-small cell lung cancer (NSCLC) patients treated with immunotherapy
err2020-09-01
err2
errOAAI
errBjoernhart, B.; Hansen, K. H.; Jorgensen, T. L.; Herrstedt, J.; Schytte, T.
errShare
errSave